None listed
Conditions
Interventions
Intervention1: LF1485: Oral administration of single LF1485 sachet in 240 mL water once a day for 28 days
Intervention2: COCZ021: Oral administration of single COCZ021 sachet in 240 mL water once a da
Sponsors
Akay Natural Ingredients Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1.Subjects with a BMI 20 to 26 kg/m2 2. physically active subjects with minimum 20 min walking/day 3.Shall not be taking any kind of daily medication for the last six months 4.Subject willing to adhere with their routine diet, physical activity, and general lifestyle throughout the study 5.Non Smokers 6.Must be willing and able to give informed consent and comply with the study procedures
Exclusion criteria
Exclusion criteria: 1.Subjects having symptoms of viral infection, including COVID-19 infection 2.Subjects with clinically significant comorbidity 3.Subjects who are on parental insulin, statins or any other lipid lowering drugs 4.Known HIV or Hepatitis B positive or any other immuno-compromised state 5.Subjects allergic to herbal products or any component of the study product 6.Currently participating or having participated in another clinical trial during the last 3 months prior to the beginning of this study 7.Any additional condition(s) that in the Investigators opinion would warrant exclusion from the study or prevent the subject from completing the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in physical performance and exercise capacityTimepoint: Day 0 , Day 14 , Day 21, Day 28 | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in Bio marker levelsTimepoint: Day 0 , Day 14 , Day 21, Day 28;Overall safety assessmentsTimepoint: Day 0 , Day 14 , Day 21, Day 28 | — |
Countries
India
Contacts
Public ContactJestin V Thomas
Leads Clinical Research and Bio Services Pvt. Ltd
Outcome results
None listed